Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

34084-50-9

Amino-7 Flunitrazepam

34084-50-9
486-25-9

Fluorenone-9

486-25-9
150168-54-0

4-Amino Fluconazole Bromide

150168-54-0
03/12/1944

Fenoterol HBr

03/12/1944
42461-84-7

Flunixin meglumine

42461-84-7
21689-14-1

Fludarabine

21689-14-1
108656-33-3

Florfenicol amine HCl

108656-33-3
1672-58-8

4-Formyl-aminoantipyrin

1672-58-8
31430-15-6

Flubendazol

31430-15-6
58306-30-2

Febantel

58306-30-2
864731-61-3

Fluralaner

864731-61-3
54143-56-5

Flecainide acetate

54143-56-5
76639-93-5

Florfenicol amine

76639-93-5
NA

Fluconazole impurity standardBP

NA
132125-60-1

Fosfomycin Impurity A

132125-60-1
79660-72-3

Fleroxacin

79660-72-3
139-91-3

Furaltadone

139-91-3
31879-05-7

Fenoprofen

31879-05-7
43210-67-9

Fenbendazole

43210-67-9
80474-14-2

Fluticasone Propionate

80474-14-2